AGI names director but profits slide

AGI Therapeutics, the Irish Stock Exchange-listed specialist drugs firm, has appointed David G Kelly as director and chief financial officer.

AGI names director but profits slide

Mr Kelly, a chartered accountant, was most recently senior vice president of Warner Chilcott (formerly Galen).

AGI yesterday posted losses for 2005 of €5.2m, up from €3.1m in 2004.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited